Clinical trial
Catalyzing Cigarette Smoking Cessation Through Harm Reduction Sampling Among People Unmotivated to Quit
NCT07199517 is registered in ClinicalTrials.gov with Abramson Cancer Center at Penn Medicine as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Catalyzing Cigarette Smoking Cessation Through Harm Reduction Sampling Among People Unmotivated to Quit
- Lead sponsor
- Abramson Cancer Center at Penn Medicine
- Phase
- Not applicable
- Overall status
- Recruiting
- Start date
- January 12, 2026
- Completion date
- July 31, 2030
- Enrollment
- 472 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
cigarette smoking, cigarette smoking behavior, tobacco use